A Prognostic Score for Myelodysplasia Based on Bone Marrow Histopathology (Hannover Score)
|To assess prognosis in a patient with primary myelofibrosis using a score based on the histopathologic findings seen in the bone marrow biopsy.|
|severity, prognosis, stage|
Examination of the bone marrow can be used to evaluate the prognosis in patients with primary myelodysplasia. This can be done independent of clinical and other laboratory data. This score was developed at the Medizinische Hochschule in Hannover, Germany.
To read more or access our algorithms and calculators, please log in or register.